Previously:
The use of puberty blockers and cross-sex hormone therapy for trans adolescents is not a new or recent development, and this protocol has been in use since the mid-1990s. Clinical data on outcomes in this population is abundant: numerous studies of trans youth who’ve taken puberty blockers have shown significant reductions in gender dysphoria, depressive and anxious symptoms, self-harm, and suicidality, along with improvements in body satisfaction and overall psychological functioning and quality of life. Despite uninformed depictions in the press as an untested treatment fraught with unknowns, adolescent transition has consistently been found to have strong beneficial effects for gender-dysphoric youth, and major medical and pediatric organizations endorse this as a suitable and necessary treatment for appropriately evaluated youth.
This is hardly so new that nobody knows what it does. So the latest study of this treatment by Tordoff et al. (2022) simply adds further confirmation to a large existing body of evidence that clearly points in one direction: adolescent transition helps trans youth. Continue reading